Amneal Pharmaceuticals In... (AMRX)

AI Score

Unlock

7.36

0.18 (2.51%)

At close: Apr 17, 2025, 3:59 PM

7.37

0.12%

Pre-market: Apr 21, 2025, 06:24 AM EDT

Amneal Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	110.55M	91.54M	25.98M	247.79M	341.38M	151.2M	213.39M	74.17M	27.37M
Short-Term Investments	n/a	2.2M	1.82M	1.17M	1.7M	1.12M	2.14M	1.85M	4.35M
Long-Term Investments	n/a	37.09M	85.59M	n/a	n/a	16.37M	n/a	n/a	n/a
Other Long-Term Assets	60.13M	18.43M	103.22M	20.61M	31.89M	44.27M	67.59M	11.26M	-481.77M
Receivables	775.73M	613.73M	741.79M	662.58M	674.21M	635.89M	565.32M	351.37M	394.79M
Inventory	612.45M	581.38M	530.74M	489.39M	490.65M	381.07M	457.22M	284.04M	266.16M
Other Current Assets	89.07M	39.49M	64.37M	74.11M	40.96M	33.13M	52.82M	35.12M	22.74M
Total Current Assets	1.59B	1.38B	1.41B	1.52B	1.55B	1.21B	1.29B	771.93M	726.11M
Property-Plant & Equipment	523.69M	550.14M	589.36M	639M	595.17M	609.15M	544.15M	486.76M	407.4M
Goodwill & Intangibles	1.33B	1.49B	1.69B	1.76B	1.83B	1.8B	2.08B	71.04M	74.37M
Total Long-Term Assets	1.91B	2.09B	2.39B	2.42B	2.45B	2.46B	3.07B	569.96M	481.77M
Total Assets	3.5B	3.47B	3.8B	3.94B	4.01B	3.67B	4.35B	1.34B	1.22B
Account Payables	258.69M	143.57M	166.84M	132.87M	154.14M	103.02M	114.85M	70.01M	60.03M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	17.43M	137.08M	n/a
Short-Term Debt	240.25M	213.13M	89.96M	30.61M	45.23M	21.48M	21.45M	89.17M	36.89M
Other Current Liabilities	598.29M	227.43M	263.11M	277.77M	207.31M	176.32M	200.83M	72.2M	63.82M
Total Current Liabilities	1.13B	846.6M	752.8M	677.24M	676.9M	550.41M	553.85M	296.88M	225.07M
Long-Term Debt	91.09M	2.43B	2.63B	2.72B	2.77B	2.61B	2.63B	1.36B	1.16B
Other Long-Term Liabilities	1.2B	83.06M	97.12M	65.43M	96.75M	35.71M	231.66M	10.28M	-921K
Total Long-Term Liabilities	1.29B	2.61B	2.84B	2.9B	2.98B	2.77B	2.9B	1.42B	1.16B
Total Liabilities	3.61B	3.45B	3.59B	3.57B	3.66B	3.32B	3.46B	1.72B	1.39B
Total Debt	331.35M	2.75B	2.85B	2.88B	2.94B	2.77B	2.69B	1.48B	n/a
Common Stock	3.1M	3.07M	3.04M	3.01M	3M	2.99M	2.99M	2.72M	2.67M
Retained Earnings	-607.06M	-490.18M	-406.18M	-276.2M	-286.82M	-377.88M	-20.92M	-382.79M	-175.17M
Comprehensive Income	-65.51M	-32.35M	9.94M	-24.83M	-41.32M	-68K	-7.75M	-14.23M	n/a
Shareholders Equity	-109.27M	19.78M	183.98M	366.97M	344.93M	346.79M	896.36M	-385.74M	-185.29M
Total Investments	n/a	39.29M	87.41M	1.17M	1.7M	17.5M	2.14M	1.85M	4.35M